Medicare Enrolled

Dr. Matthew Petitt, DO

Dermatopathology Physician · Pasadena, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4419 CRENSHAW RD, Pasadena, TX 77504
2819915944
In practice since 2007 (18 years)
NPI: 1912101593 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Petitt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petitt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Petitt

Dr. Matthew Petitt is a dermatopathology physician in Pasadena, TX, with 18 years in practice. Based on federal Medicare data, Dr. Petitt performed 9,549 Medicare services across 4,970 unique beneficiaries.

Between the years covered by Open Payments, Dr. Petitt received a total of $20,308 from 52 pharmaceutical and/or device companies across 1024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Petitt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 16% volume in TX$ $20,308 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,549
Medicare services
Top 16% in TX for dermatopathology physician
4,970
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~530 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tissue pathology examination, moderate complexity4,447$57$170
Destruction of precancerous skin growths, 2-141,402$5$25
Tissue staining for diagnosis, additional652$23$47
Office visit, established patient (20-29 min)463$67$152
Destruction of precancerous skin growth, 1437$35$111
Skin biopsy, tangential380$69$175
Pathology examination of tissue using a microscope, moderately low complexity253$34$96
Office visit, established patient (30-39 min)230$92$215
Biopsy of related skin growth, each additional growth229$40$89
Tissue staining for diagnosis, initial221$28$58
Destruction of skin growths (warts/lesions), 1-14132$85$191
Special stained specimen slides to identify organisms including interpretation and report122$92$186
New patient office visit (30-44 min)82$78$186
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm47$340$731
Special stained specimen slides to examine tissue including interpretation and report47$68$134
Destruction of precancer skin growth, 15 or more growths40$127$278
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm34$108$300
Steroid injection (triamcinolone)33$1$5
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm32$102$416
New patient office visit (45-59 min)32$119$279
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm30$388$806
Complicated repair of wound of trunk, 2.6-7.5 cm26$304$684
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm26$110$317
Punch biopsy, first skin growth25$83$219
Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm25$112$455
Biopsy of ear22$56$167
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm19$117$473
Destruction of skin growth, 15 or more growths14$95$224
Office visit, established patient (10-19 min)13$47$93
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm12$144$346
Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm11$105$429
All potassium hydroxide (koh) preparations11$6$7
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$20,308
Total received (2018-2024)
Avg $2,901/year across 7 years
Top 14% in TX for dermatopathology physician
52
Companies
1,024
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,994 (98.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$314 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,297
2023
$4,331
2022
$3,187
2021
$2,408
2020
$2,091
2019
$2,127
2018
$1,866

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,108
Novartis Pharmaceuticals Corporation
$1,967
ABBVIE INC.
$1,888
Regeneron Healthcare Solutions, Inc.
$1,288
Lilly USA, LLC
$1,268
GENZYME CORPORATION
$1,080
LEO Pharma Inc.
$1,071
PFIZER INC.
$969
Sun Pharmaceutical Industries Inc.
$829
Amgen Inc.
$827
AbbVie, Inc.
$633
Arcutis Biotherapeutics, Inc.
$546
Incyte Corporation
$502
AbbVie Inc.
$499
Dermavant Sciences, Inc.
$447
UCB, Inc.
$400
Ortho Dermatologics, a division of Bausch Health US, LLC
$380
Galderma Laboratories, L.P.
$373
Organogenesis Inc.
$365
Celgene Corporation
$348
Paratek Pharmaceuticals, Inc.
$302
Almirall LLC
$273
MAYNE PHARMA INC.
$238
Genentech USA, Inc.
$218
Hill Dermaceuticals, Inc.
$213
SUN PHARMACEUTICAL INDUSTRIES INC.
$161
Mayne Pharma Inc.
$140
Encore Dermatology Inc.
$116
DERMIRA, INC.
$114
EPI Health, LLC
$85
Mallinckrodt Hospital Products Inc.
$73
Journey Medical Corporation
$71
Medimetriks Pharmaceuticals, Inc.
$64
VYNE Pharmaceuticals Inc.
$51
Biofrontera Inc.
$44
Tempus AI, Inc
$37
E.R. Squibb & Sons, L.L.C.
$36
DUSA Pharmaceuticals, Inc.
$32
Nabriva Therapeutics, plc
$27
Mylan Pharmaceuticals Inc.
$25
Sebela Pharmaceuticals Inc.
$24
Merck Sharp & Dohme Corporation
$22
ORGANOGENESIS INC.
$20
Teva Pharmaceuticals USA, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Bayer HealthCare Pharmaceuticals Inc.
$16
AstraZeneca Pharmaceuticals LP
$15
Melinta Therapeutics, Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$14
SANOFI-AVENTIS U.S. LLC
$11
Promius Pharma LLC
$11
Aclaris Therapeutics, Inc.
$11
Top 3 companies account for 29.4% of total payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ACTHAR · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Ameluz · BLU-U · BRYHALI · Baxdela · Bensal HP · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindacin ETZ · Cordran · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DermOtic · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · EVUSHELD · Enbrel · Erivedge · FINACEA · Finacea · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · Merlin Test · NUZYRA · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PRAMOSONE · Puraply · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIMLANDI · SIVEXTRO · SKYRIZI · SOOLANTRA · SORILUX · SPEVIGO · Sernivo Spray · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · TargaDox · Tremfya · VALCHLOR · VTAMA · Veltin · Winlevi · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $213 per 100 Medicare services performed
Looking for a dermatopathology physician in Pasadena?
Compare dermatopathology physicians in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse dermatopathology physicians nearby

Geographic Context

Dermatopathology Physicians within 10 mi
14
Per 100K population
0.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE SOUTHEAST
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Petitt is a mixed practice specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (low-engagement, top 14%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Petitt experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Petitt performed 4,447 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Petitt receive payments from pharmaceutical companies?
Yes. Dr. Petitt received a total of $20,308 from 52 companies across 1,024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Petitt's costs compare to other dermatopathology physicians in Pasadena?
Dr. Petitt's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Petitt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →